Eszter Nagy

Eszter Nagy

Auto-generated profile, based on publicly available information

Eszter Nagy

Department of Laboratory Medicine, Semmelweis University, Budapest, Hungary

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2026 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
HHHanga Réka Horváth
Hanga Réka Horváth
NANoémi Andrási
Noémi Andrási
ENEszter Nagy
Eszter Nagy
ÉIÉva Imreh
Éva Imreh
HFHenriette Farkas
Henriette Farkas
Background: Bradykinin-mediated hereditary angioedema due to C1 inhibitor deficiency (HAE-C1INH) is often hard to differentiate from mast cell (MC) mediated diseases. MCs can be activated by numerous stimuli, leading to the release of various mediators. Recently, crosstalk between MCs and the complement system has been reported. Clinical observations report a higher prevalence of MC-mediated diseases in the HAE-C1INH population than in the general population. Objective: To investigate MC activation in HAE-C1INH. Methods: Serum samples from patients during angioedema attack (HAE-A) and during symptom-free period (HAE-SF), as well as from non-angioedema control subjects were examined. Patients and control subjects had no history of allergic disease and normal levels of both nutritional and inhalant specific IgE. Tryptase, chymase, platelet-activating factor (PAF), leukotriene B4 (LTB4), diamine oxidase (DAO), and eosinophil cationic protein (ECP) were measured. Results: Serum level of chymase was higher in both HAE-C1INH groups than in the control group ( p = 0.020 in both comparisons), while no difference was found between the HAE-A and HAE-SF groups. DAO and ECP did not differ from the control group, but their levels increased during angioedema attack compared to the asymptomatic state ( p = 0.018 and 0.004, respectively). No difference was found in the levels of the other mediators in any comparison. Chymase levels during the symptom-free period were significantly lower in those patients who had more than 3 HAE attack in the three months following sampling than in those who had less than that ( p = 0.012). No other mediators showed a difference between these two groups. Conclusion: Significantly higher chymase levels in HAE-C1INH patients raise the possibility of the activation of a specific subset of MCs in HAE-C1INH patients. Elevation of DAO and ECP levels during HAE attacks indicates the involvement of bradykinin-independent pathways in edema formation during HAE attacks.

1 September 2026 in Journal of Translational Autoimmunity
Verified
Journal Article
Open access
WVWim Vroemen
Wim Vroemen
MDM.A. Dragon-Durey
M.A. Dragon-Durey
YAY. Allenbach
Y. Allenbach
TBT. Berki
T. Berki
SČS. Čučnik
S. Čučnik
CBC. Bonroy
C. Bonroy